No Data
No Data
JonesTrading Sticks to Their Buy Rating for TriSalus Life Sciences (TLSI)
Navigating the Financial Tightrope: Trisalus Life Sciences' High-Stakes Debt Strategy With OrbiMed
Earnings Call Summary | TriSalus Life Sciences(TLSI.US) Q1 2024 Earnings Conference
The following is a summary of the TriSalus Life Sciences, Inc. (TLSI) Q1 2024 Earnings Call Transcript:Financial Performance:TriSalus Life Sciences reported a Q1 2024 revenue of $6.5 million, a signif
TriSalus Life Sciences, Inc. (TLSI) Q1 2024 Earnings Call Transcript
TriSalus Life Sciences, Inc. (TLSI) Q1 2024 Earnings Call Transcript
10-Q: Quarterly report
Express News | TriSalus Life Sciences Inc: Full Year Sales Growth Expected to Exceed 50%
No Data